On the public citation graph
Valacyclovir for Episodic Treatment of Genital Herpes: A Shorter 3‐Day Treatment Course Compared with 5‐Day Treatment
0 signed · 98 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archderm.134.2.185openalex-snapshot
A Randomized, Placebo-Controlled Comparison of Oral Valacyclovir and Acyclovir in Immunocompetent Patients With Recurrent Genital Herpes Infections
inferredcites →https://doi.org/10.1001/archinte.156.15.1729openalex-snapshot
A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group
inferredcites →https://doi.org/10.1016/s0011-5029(00)90012-9openalex-snapshot
Herpes simplex type 2 infections—An update
inferredcites →https://doi.org/10.1056/nejm199710163371601openalex-snapshot
Herpes Simplex Virus Type 2 in the United States, 1976 to 1994
inferredcites →https://doi.org/10.1097/00006254-199803000-00003openalex-snapshot
Herpes Simplex Virus Type 2 in the United States, 1976 to 1994
inferredcites →https://doi.org/10.1136/sti.73.2.110openalex-snapshot
Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group.
inferredcites →https://doi.org/10.1136/sti.75.6.398openalex-snapshot
Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection
inferredcites →https://doi.org/10.7326/0003-4819-121-11-199412010-00004openalex-snapshot
Recurrence Rates in Genital Herpes after Symptomatic First-Episode Infection
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4453382openalex-extracted
Safety and Efficacy of Single HDIT101 Infusion Versus Episodic Valacyclovir Standard-of-Care in Patients with Chronic Recurrent Anogenital Herpes Simplex Virus 2 (HSV-2) Infection: A Multicentre, Parallel-Group Design, Randomised, Double-Blind, Double-Dummy Phase 2 Trial
inferred← citeshttps://doi.org/10.1001/archinte.168.11.1137openalex-snapshot
The Treatment of Herpes Simplex Infections An Evidence-Based Review
inferred← citeshttps://doi.org/10.1002/14651858.cd009036openalex-snapshot
Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients
inferred← citeshttps://doi.org/10.1002/14651858.cd009036.pub2openalex-snapshot
Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients
inferred← citeshttps://doi.org/10.1002/9780470571224.pse425openalex-snapshot
Antiviral Market Overview
inferred← citeshttps://doi.org/10.1002/9780470692172.ch13openalex-snapshot
Sexually Transmitted and Genital Infections
inferred← citeshttps://doi.org/10.1002/9780470988336.ch10openalex-snapshot
Sexually Transmitted Infections
inferred← citeshttps://doi.org/10.1002/9781444301601.ch10openalex-snapshot
Sexually Transmitted Infections
inferred← citeshttps://doi.org/10.1007/978-3-030-66049-9_18openalex-snapshot
Sexually Transmitted Infections of the Colon and Rectum
inferred← citeshttps://doi.org/10.1007/978-3-642-55661-6_93openalex-snapshot
Sexuell übertragbare Erkrankungen
inferred← citeshttps://doi.org/10.1007/s00404-006-0234-zopenalex-snapshot
Single-day therapy: an expert opinion on a recent development for the episodic treatment of recurrent genital herpes
inferred← citeshttps://doi.org/10.1007/s10227-002-0140-3openalex-snapshot
Valacyclovir in the Treatment of Herpes Simplex, Herpes Zoster, and Other Viral Infections
inferred← citeshttps://doi.org/10.1016/b978-0-443-06839-3.00041-2openalex-snapshot
Antiviral Drugs (Other than Antiretrovirals)
inferred← citeshttps://doi.org/10.1016/b978-0-444-53272-5.50006-6openalex-snapshot
ANTIVIRAL DRUGS, INCLUDING IMMUNOGLOBULINS AND INTERFERONS
inferred← citeshttps://doi.org/10.1016/b978-0-7020-4064-1.00056-7openalex-snapshot
Sexually transmitted diseases
inferred← citeshttps://doi.org/10.1016/b978-1-4557-4801-3.00045-xopenalex-snapshot
Antivirals against Herpes Viruses
inferred← citeshttps://doi.org/10.1016/j.annder.2026.103507openalex-snapshot
2024 guidelines (S3) for the therapeutic management of patients with genital herpes
inferred← citeshttps://doi.org/10.1016/j.annemergmed.2011.04.006openalex-snapshot
Sexually Transmitted Diseases Treatment Guidelines, 2010
inferred← citeshttps://doi.org/10.1016/j.clindermatol.2025.09.010openalex-snapshot
Herpes simplex virus (update on dermatologic aspects of sexually transmitted disease and human immunodeficiency virus)
inferred← citeshttps://doi.org/10.1016/j.eimc.2009.11.002openalex-snapshot
Características de los fármacos antivíricos frente a virus del grupo herpes actualización 2009
inferred← citeshttps://doi.org/10.1016/j.jinf.2004.07.010openalex-snapshot
Medical treatment of viral pneumonia including SARS in immunocompetent adult
inferred← citeshttps://doi.org/10.1016/j.jpag.2007.04.004openalex-snapshot
Genital Herpes and the Teen Female
inferred← citeshttps://doi.org/10.1016/j.pcl.2005.02.006openalex-snapshot
Antiviral Therapies in Children: Has Their Time Arrived?
inferred← citeshttps://doi.org/10.1016/j.phrs.2025.107999openalex-snapshot
Safety and efficacy of monoclonal antibody therapy in patients with chronic herpes simplex virus-2 genital infections: MATCH-2, a randomized double-blinded, parallel-group phase 2 multi-center trial
inferred← citeshttps://doi.org/10.1016/s0889-8545(03)00087-1openalex-snapshot
Treatment of sexually transmitted diseases in women
inferred← citeshttps://doi.org/10.1017/cbo9780511545313.037openalex-snapshot
HSV: persistence in the population: epidemiology, transmission
inferred← citeshttps://doi.org/10.1017/cbo9780511545313.045openalex-snapshot
HCMV: persistence in the population: epidemiology and transmisson
inferred← citeshttps://doi.org/10.1017/cbo9780511545313.065openalex-snapshot
Antiviral therapy of HSV-1 and -2
inferred← citeshttps://doi.org/10.1046/j.1365-2133.2003.05062.xopenalex-snapshot
Valaciclovir as a single dose during prodrome of herpes facialis: a pilot randomized double-blind clinical trial
inferred← citeshttps://doi.org/10.1055/s-0042-1755188openalex-snapshot
Benign Anorectal Disorder Management in Low-Resource Settings
inferred← citeshttps://doi.org/10.1067/mjd.2002.121033openalex-snapshot
Antiviral agents: Nonantiviral drugs
inferred← citeshttps://doi.org/10.1071/sh08013openalex-snapshot
2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST study
inferred← citeshttps://doi.org/10.1071/sh08013_coopenalex-snapshot
Corrigendum to: 2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST study
inferred← citeshttps://doi.org/10.1071/sh08033openalex-snapshot
Making the most of episodic antiviral therapy for genital herpes
inferred← citeshttps://doi.org/10.1086/342959openalex-snapshot
Progress in Meeting Today’s Demands in Genital Herpes: An Overview of Current Management
inferred← citeshttps://doi.org/10.1086/343738openalex-snapshot
Valacyclovir in the Treatment of Facial Herpes Simplex Virus Infection
inferred← citeshttps://doi.org/10.1086/444457openalex-snapshot
Clinic-Initiated, Twice-Daily Oral Famciclovir for Treatment of Recurrent Genital Herpes: A Randomized, Double-Blind, Controlled Trial
inferred← citeshttps://doi.org/10.1086/498521openalex-snapshot
Single-Day, Patient-Initiated Famciclovir Therapy for Recurrent Genital Herpes: A Randomized, Double-Blind, Placebo-Controlled Trial
inferred← citeshttps://doi.org/10.1086/590561openalex-snapshot
Single‐Day, Patient‐Initiated Famciclovir Therapy versus 3‐Day Valacyclovir Regimen for Recurrent Genital Herpes: A Randomized, Double‐Blind, Comparative Trial
inferred← citeshttps://doi.org/10.1086/590564openalex-snapshot
Determinant Roles of Environmental Contamination and Noncompliance with Standard Precautions in the Risk of Hepatitis C Virus Transmission in a Hemodialysis Unit
inferred← citeshttps://doi.org/10.1086/591913openalex-snapshot
Rapidly Cleared Episodes of Herpes Simplex Virus Reactivation in Immunocompetent Adults
inferred← citeshttps://doi.org/10.1089/152460902317586038openalex-snapshot
Women's Health LiteratureWatch
inferred← citeshttps://doi.org/10.1093/infdis/jis019openalex-snapshot
ASP2151 for the Treatment of Genital Herpes: A Randomized, Double-Blind, Placebo- and Valacyclovir-Controlled, Dose-Finding Study
inferred← citeshttps://doi.org/10.1097/00006205-200311000-00012openalex-snapshot
Herpes Simplex Virus Type 2: An Update
inferred← citeshttps://doi.org/10.1097/00008480-200308000-00006openalex-snapshot
Sexually transmitted diseases treatment guidelines
inferred← citeshttps://doi.org/10.1097/01.olq.0000237853.69443.71openalex-snapshot
A Comparison of One Year of Episodic or Suppressive Treatment of Recurrent Genital Herpes With Valacyclovir
inferred← citeshttps://doi.org/10.1097/ipc.0b013e3181aba461openalex-snapshot
The Bidirectional Interactions of Human Immunodeficiency Virus-1 and Sexually Transmitted Infections
inferred← citeshttps://doi.org/10.1097/olq.0b013e31815e4190openalex-snapshot
One-Day Regimen of Valacyclovir for Treatment of Recurrent Genital Herpes Simplex Virus 2 Infection
inferred← citeshttps://doi.org/10.1097/olq.0b013e3181e2d156openalex-snapshot
Modern Management of Genital Ulcer Disease—Frappez Fort et Frappez Vite
inferred← citeshttps://doi.org/10.1111/j.1365-4632.2009.04375.xopenalex-snapshot
Herpes simplex virus and human papillomavirus genital infections: new and investigational therapeutic options
inferred← citeshttps://doi.org/10.1111/j.1529-8019.2008.00191.xopenalex-snapshot
Recent advances in management of genital ulcer disease and anogenital warts
inferred← citeshttps://doi.org/10.1111/jdv.20450openalex-snapshot
2024 European guidelines for the management of genital herpes
inferred← citeshttps://doi.org/10.1128/9781555815981.ch12openalex-snapshot
Antiherpesvirus, Anti?Hepatitis Virus, and Anti?Respiratory Virus Agents
inferred← citeshttps://doi.org/10.1136/sti.2003.007922openalex-snapshot
Patient satisfaction with care for genital herpes: insights from a global survey
inferred← citeshttps://doi.org/10.1155/2003/984698openalex-snapshot
Contemporary Antiviral Drug Regimens for the Prevention and Treatment of Orolabial and Anogenital Herpes Simplex Virus Infection in the Normal Host: Four Approved Indications and 13 Off‐Label Uses
inferred← citeshttps://doi.org/10.11606/d.5.2021.tde-27082021-133126openalex-snapshot
Efeitos da melatonina no tratamento supressivo do herpes genital recorrente
inferred← citeshttps://doi.org/10.1177/0956462415580512openalex-snapshot
2014 UK national guideline for the management of anogenital herpes
inferred← citeshttps://doi.org/10.1177/0956462417727194openalex-snapshot
2017 European guidelines for the management of genital herpes
inferred← citeshttps://doi.org/10.1177/09564624241282396openalex-snapshot
British Association of Sexual Health and HIV UK national guideline for the management of anogenital herpes, 2024
inferred← citeshttps://doi.org/10.1185/030079906x112642openalex-snapshot
Single-day famciclovir therapy for recurrent genital herpes
inferred← citeshttps://doi.org/10.1185/03007990802664678openalex-snapshot
Single-day famciclovir for the treatment of genital herpes: follow-up results of time to next recurrence and assessment of antiviral resistance
inferred← citeshttps://doi.org/10.1185/03007990903554471openalex-snapshot
One-day famciclovir vs. placebo in patient-initiated episodic treatment of recurrent genital herpes in immunocompetent Black patients
inferred← citeshttps://doi.org/10.1258/ijsa.2010.010278openalex-snapshot
European guideline for the management of genital herpes, 2010
inferred← citeshttps://doi.org/10.1345/aph.1d148openalex-snapshot
Short-Course Oral Antiviral Treatment for Recurrent Genital Herpes
inferred← citeshttps://doi.org/10.15585/mmwr.rr7004a1openalex-snapshot
Sexually Transmitted Infections Treatment Guidelines, 2021
inferred← citeshttps://doi.org/10.1586/14787210.1.2.283openalex-snapshot
Review of antiviral therapy for herpes labialis, genital herpes and herpes zoster
inferred← citeshttps://doi.org/10.1586/14787210.4.3.367openalex-snapshot
Valacyclovir for the treatment of genital herpes
inferred← citeshttps://doi.org/10.1783/147118909789587376openalex-snapshot
Aspects of herpes simplex virus: a clinical review
inferred← citeshttps://doi.org/10.18773/austprescr.2015.070openalex-snapshot
Updating the management of sexually transmitted infections
inferred← citeshttps://doi.org/10.2147/tcrm.s1664openalex-snapshot
Single-day treatment for orolabial and genital herpes: a brief review of pathogenesis and pharmacology
inferred← citeshttps://doi.org/10.2165/00115677-200412020-00004openalex-snapshot
Management of Genital Herpes
inferred← citeshttps://doi.org/10.2165/00128071-200607040-00001openalex-snapshot
Single-Day Therapy for Recurrent Genital Herpes
inferred← citeshttps://doi.org/10.3390/biomedicines11041088openalex-snapshot
Effects of Melatonin Alone or Associated with Acyclovir on the Suppressive Treatment of Recurrent Genital Herpes: A Prospective, Randomized, and Double-Blind Study
inferred← citeshttps://doi.org/10.3390/biomedicines12030522openalex-snapshot
Urinary Viral Spectrum in Patients with Interstitial Cystitis/Bladder Pain Syndrome and the Clinical Efficacy of Valacyclovir Treatment
inferred← citeshttps://doi.org/10.4414/saez.2005.11126openalex-snapshot
Schweizer Empfehlungen für das Management des Herpes genitalis und der Herpes-simplex-Virus-Infektion des Neugeborenen
inferred← citeshttps://doi.org/10.4414/smw.2004.10572openalex-snapshot
Swiss recommendations for the management of genital herpes and herpes simplex virus infection of the neonate
inferred← citeshttps://doi.org/10.64471/30453003-24.1hla-09openalex-snapshot
Herpetic Lesions Affecting the Oral Cavity- Etiology, Diagnosis, Medication, and Laser Therapy: A Literature Review
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.